Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2003;42:895-900
Published online before print September 29, 2003, doi: 10.1161/01.HYP.0000095613.41961.6E
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
42/5/895    most recent
01.HYP.0000095613.41961.6Ev1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, H.
Right arrow Articles by Morrish, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, H.
Right arrow Articles by Morrish, D. W.
Related Collections
Right arrow Other hypertension

(Hypertension. 2003;42:895.)
© 2003 American Heart Association, Inc.


Scientific Contributions

Adrenomedullin Is Decreased in Preeclampsia Because of Failed Response to Epidermal Growth Factor and Impaired Syncytialization

Hongshi Li; Jamal Dakour; Susan Kaufman; Larry J. Guilbert; Bonnie Winkler-Lowen; Donald W. Morrish

From the Departments of Medicine (H.L., J.D., D.W.M.), Physiology (S.K.), and Medical Microbiology and Immunology (L.J.G., B.W.-L.), University of Alberta, Edmonton, Alberta, Canada.

Correspondence to Dr Donald W. Morrish, Department of Medicine, 362 Heritage Medical Research Centre, University of Alberta, Edmonton, Alberta, Canada T6G 2S2. E-mail dmorrish{at}gpu.srv.ualberta.ca

To explore the mechanisms of adrenomedullin (ADM) regulation in normal and preeclamptic (PE) states, we determined placental production of ADM and ADM regulation by cytokines. Isolated, purified cytotrophoblast cultures from normal (n=8) and PE (n=10) placentas were cultured for 3 days in the absence or presence of 10 ng/mL epidermal growth factor (EGF), 1 ng/mL transforming growth factor (TGF)-ß1, 10 ng/mL tumor necrosis factor (TNF)-{alpha}, or 100 U/mL interferon (IFN)-{gamma}. Cells were also cultured for 3 days in 10% fetal bovine serum for determination of syncytial formation by desmoplakin staining. Pieces of normal and PE placentas were snap-frozen for ADM mRNA measurement. Results showed that basal ADM production into culture medium by radioimmunoassay was significantly lower in PE placental cells. EGF significantly stimulated ADM production in normal trophoblasts but did not in PE placentas. None of the factors TNF-{alpha}, TGF-ß1, or IFN-{gamma} altered ADM secretion in either normal or PE placentas. ADM expression by Northern blot analysis demonstrated a 34.3±8.3% reduction in mRNA expression in PE placentas. Syncytialization, as assessed by desmoplakin-outlined syncytial units, was decreased in PE placentas (day 3: normal, 16.7±1.3%; PE, 5.5±2.0%; P<0.01, ANOVA). However, there was a normal increment in syncytialization in response to EGF in normal and PE trophoblast preparations (EGF day 3: normal, 43.8±5.6%; PE, 46.1±12.3%). We conclude that spontaneous placental syncytialization is impaired in PE and that ADM production is markedly reduced in PE, possibly owing to an impaired EGF response. These abnormalities indicate poor placental production of ADM as the likely cause of a failed compensatory increase in maternal serum ADM levels in PE.


Key Words: adrenomedullin • preeclampsia • interferon • epidermal growth factor • tumor necrosis factor • pregnancy




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
H. E. M. zu Schwabedissen, M. Grube, A. Dreisbach, G. Jedlitschky, K. Meissner, K. Linnemann, C. Fusch, C. A. Ritter, U. Volker, and H. K. Kroemer
EPIDERMAL GROWTH FACTOR-MEDIATED ACTIVATION OF THE MAP KINASE CASCADE RESULTS IN ALTERED EXPRESSION AND FUNCTION OF ABCG2 (BCRP)
Drug Metab. Dispos., April 1, 2006; 34(4): 524 - 533.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Li, J. Dakour, L. J. Guilbert, B. Winkler-Lowen, F. Lyall, and D. W. Morrish
PL74, a Novel Member of the Transforming Growth Factor-{beta} Superfamily, Is Overexpressed in Preeclampsia and Causes Apoptosis in Trophoblast Cells
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 3045 - 3053.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
I. Knerr, B. Huppertz, C. Weigel, J. Dotsch, C. Wich, R.L. Schild, M.W. Beckmann, and W. Rascher
Endogenous retroviral syncytin: compilation of experimental research on syncytin and its possible role in normal and disturbed human placentogenesis
Mol. Hum. Reprod., August 1, 2004; 10(8): 581 - 588.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. Balasch, M. Guimera, O. Martinez-Pasarell, J. Ros, J. A. Vanrell, and W. Jimenez
Adrenomedullin and vascular endothelial growth factor production by follicular fluid macrophages and granulosa cells
Hum. Reprod., April 1, 2004; 19(4): 808 - 814.
[Abstract] [Full Text] [PDF]